ArticleMolecular and cellular biochemistry2026
RNase A is inhibited by the cysteine-rich protein thionein but not by the metal-containing form metallothionein.
Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metallothionein (MT) is a cysteine-rich protein that displays a high redox activity, acts like an acute phase protein, and forms metal-thiolate clusters. However, little is known about how the presence of metals in MT or their absence in Thionein (T) modify the structure of the protein and if such differential conformations alter the protein-protein interactions that MT/T establishes with other proteins. Ribonucleases (RNases) are a group of enzymes that hydrolyze different classes of RNA and due to the relevance of their function, they are highly regulated by specific inhibitors. Earlier results showed a decrease in RNase activity during an inflammatory process that appears to be a consequence of a de novo synthesis of an unidentified RNase inhibitor (RI) (Brambila et al in Exp Mol Pathol 71:125–131, https://doi.org/10.1006/exmp.2001.2383 , 2001). Therefore, we performed experimental studies to evaluate the ability of MT/T to inhibit RNase A activity in vitro. Computational methods were utilized to characterize the tertiary structure of MT/T in the presence and absence of zinc ions and to evaluate the stability of a complex with RNase A. Our results show that only in the absence of metals, T, the homodimeric protein has an inhibitory effect on RNase A activity via a mechanism that involves the formation of a complex between RNase A and T by specific interactions. Also, the involvement of residues, including cysteines that coordinate the cations, that participate in intermolecular interactions in the metal-bound form, aids in explaining the metal dependent inhibitory properties in the metal-free protein. This work suggests an additional role of T in the regulation of enzyme activity and protein synthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.